Eikon Therapeutics

EIKNNasdaq United States Health Care Biotechnology: Biological Products (No Diagnostic Substances)

Market cap

$502.948 M

$9.29 +0.87%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

—

Not reported

Shares outstanding

54,138,628

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Biological Products (No Diagnostic Substances) — ranked by market cap

All 160 →

#65RegenxbioRGNX$554.2M
#66Artiva BiotherapeuticsARTV$550.9M
#67Eikon TherapeuticsEIKN$502.9M
#68Valneva SEVALN$502.9M
#69ProkidneyPROK$495.4M

Where these numbers come from

Share counts and financials for Eikon Therapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.